Cytiva opens bioreactor manufacturing facility in Shrewsbury, Massachusetts

Cytiva opened a new 80,000 ft² manufacturing facility in Shrewsbury, Massachusetts, USA in December 2020 for producing Xcellerex XDR bioreactors. The facility is part of a $500 million five-year global expansion plan and will create approximately 200 jobs.

“The new manufacturing facility has been developed as a part of the company’s five-year plan to expand its global manufacturing capacity with a total investment of $500m.”pharmaceutical-technology.com

• 1 source
• pharmaceutical-technology.comCytiva New Manufacturing Facility, Shrewsbury, Massachusetts, USAHemanthJan 15, 2021

Summarized from public sources; check the original articles before acting on it.